Texas ( Mar. 04, 2013) Wax Ink has issued a No Investment Interest rating for The Advisory Board Company (Nasdaq: ABCO) based on a recent baseline equity review which placed fair value between $21-$28.
The stock closed recently at $52.45, approximately 310% above the fair value buy target for the stock and approximately 99% above the fair value close target for the stock. The recent close is 5% below analysts’ $55.00 median target for the stock.
Based on the recent close, the stock has a trailing twelve month PE of 49, and PEG Ratio of 223.
In the past 52 weeks, share prices have moved between a high of $55.06 and a low of $39.73. With the recent $52.45 close, the stock is trading 5% below the 52 week high and 24% above the 52 week low.
The Advisory Board Company provides best practices research and analysis including software tools and advisory services primarily to hospitals and health care organizations.
All valuations are based on the listed company’s most recent SEC annual filing, and all prices are per share.
Wax Ink is a baseline equity research company comprised of individual investors, NOT licensed or registered with ANY government agency.
Powered by Facebook Comments